145 related articles for article (PubMed ID: 9825002)
21. Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix.
Monnier-Benoit S; Mauny F; Riethmuller D; Guerrini JS; Căpîlna M; Félix S; Seillès E; Mougin C; Prétet JL
Gynecol Oncol; 2006 Jul; 102(1):22-31. PubMed ID: 16427684
[TBL] [Abstract][Full Text] [Related]
22. Incidence of cervical squamous intraepithelial lesions in HIV-infected women.
Ellerbrock TV; Chiasson MA; Bush TJ; Sun XW; Sawo D; Brudney K; Wright TC
JAMA; 2000 Feb; 283(8):1031-7. PubMed ID: 10697063
[TBL] [Abstract][Full Text] [Related]
23. Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesions.
Strickler HD; Schiffman MH; Eklund C; Glass AG; Scott DR; Sherman ME; Wacholder S; Kurman RJ; Manos MM; Schiller JT; Dillner J
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):183-8. PubMed ID: 9138661
[TBL] [Abstract][Full Text] [Related]
24. Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women.
Delmas MC; Larsen C; van Benthem B; Hamers FF; Bergeron C; Poveda JD; Anzén B; van den Hoek A; Meier F; Peña JM; Savonius H; Sperandeo D; Suligoi B; Vernazza P; Brunet JB
AIDS; 2000 Aug; 14(12):1775-84. PubMed ID: 10985315
[TBL] [Abstract][Full Text] [Related]
25. Detection of HPV 52, 58 and 87 in cervicovaginal intraepithelial lesions of HIV infected women.
Haas S; Park TW; Voigt E; Büttner R; Merkelbach-Bruse S
Int J Mol Med; 2005 Nov; 16(5):815-9. PubMed ID: 16211249
[TBL] [Abstract][Full Text] [Related]
26. Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica.
Ung A; Kramer TR; Schiffman M; Herrero R; Bratti MC; Burk RD; Swanson CA; Sherman ME; Hutchinson ML; Alfaro M; Morales J; Balmaceda I; Hildesheim A
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):249-53. PubMed ID: 10090303
[TBL] [Abstract][Full Text] [Related]
27. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
Khouadri S; Villa LL; Gagnon S; Koushik A; Richardson H; Matlashewski G; Roger M; Ferenczy AS; Franco EL; Coutlée F
Int J Cancer; 2007 Dec; 121(12):2674-81. PubMed ID: 17708553
[TBL] [Abstract][Full Text] [Related]
28. High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV.
Fontaine J; Hankins C; Mayrand MH; Lefevre J; Money D; Gagnon S; Rachlis A; Pourreaux K; Ferenczy A; Coutlée F;
AIDS; 2005 May; 19(8):785-94. PubMed ID: 15867492
[TBL] [Abstract][Full Text] [Related]
29. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.
Bontkes HJ; de Gruijl TD; Walboomers JM; Schiller JT; Dillner J; Helmerhorst TJ; Verheijen RH; Scheper RJ; Meijer CJ
J Gen Virol; 1999 Feb; 80 ( Pt 2)():409-417. PubMed ID: 10073701
[TBL] [Abstract][Full Text] [Related]
30. Langerhans cell density in cervical intraepithelial neoplasia associated with human papillomavirus infection in HIV-infected and HIV-noninfected Brazilian women.
Zimmermmann JB; Gobbi H; Alves MJ; Quirino MG; Melo VH
Int J Gynecol Cancer; 2012 Oct; 22(8):1291-6. PubMed ID: 22932260
[TBL] [Abstract][Full Text] [Related]
31. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
[TBL] [Abstract][Full Text] [Related]
32. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions.
Kim CJ; Jeong JK; Park M; Park TS; Park TC; Namkoong SE; Park JS
Gynecol Oncol; 2003 May; 89(2):210-7. PubMed ID: 12713982
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.
Schlecht NF; Platt RW; Duarte-Franco E; Costa MC; Sobrinho JP; Prado JC; Ferenczy A; Rohan TE; Villa LL; Franco EL
J Natl Cancer Inst; 2003 Sep; 95(17):1336-43. PubMed ID: 12953088
[TBL] [Abstract][Full Text] [Related]
34. Cervical abnormalities, human papillomavirus, and human immunodeficiency virus infections in women in Malawi.
Motti PG; Dallabetta GA; Daniel RW; Canner JK; Chiphangwi JD; Liomba GN; Yang L; Shah KV
J Infect Dis; 1996 Mar; 173(3):714-7. PubMed ID: 8627037
[TBL] [Abstract][Full Text] [Related]
35. Mucosal immunoglobulin-A and -G responses to oncogenic human papilloma virus capsids.
Sasagawa T; Rose RC; Azar KK; Sakai A; Inoue M
Int J Cancer; 2003 Apr; 104(3):328-35. PubMed ID: 12569556
[TBL] [Abstract][Full Text] [Related]
36. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
Jain BB; Adhikary T; Sadhukhan PC; Nandi A
J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
[TBL] [Abstract][Full Text] [Related]
37. Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia.
Gill DK; Bible JM; Biswas C; Kell B; Best JM; Punchard NA; Cason J
J Gen Virol; 1998 Aug; 79 ( Pt 8)():1971-6. PubMed ID: 9714245
[TBL] [Abstract][Full Text] [Related]
38. Lower genital tract intraepithelial neoplasia in HIV-infected women: guidelines for evaluation and management.
Spitzer M
Obstet Gynecol Surv; 1999 Feb; 54(2):131-7. PubMed ID: 9950005
[TBL] [Abstract][Full Text] [Related]
39. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women.
Ahdieh L; Muñoz A; Vlahov D; Trimble CL; Timpson LA; Shah K
Am J Epidemiol; 2000 Jun; 151(12):1148-57. PubMed ID: 10905527
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection.
Temmerman M; Tyndall MW; Kidula N; Claeys P; Muchiri L; Quint W
Int J Gynaecol Obstet; 1999 May; 65(2):171-81. PubMed ID: 10405062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
